Application of HPLC-ICP-MS to speciation of cisplatin and its degradation products in water containing different chloride concentrations and in human urine

Cisplatin, mono- and diaquacisplatin were measured in aquatic samples and in diluted urine of a cancer patient by HPLC-ICP-MS. On-line IDMS was applied for accurate, species unspecific quantification. Limits of detection of 0.74, 0.69 and 0.65 mug L-1 (3 s criterion) were calculated for cisplatin, monoaqua- and diaquacisplatin, respectively. Degradation kinetics of 6x10(-6) M cisplatin were determined over a period of 48 h in solutions containing 100, 50 and 0 mg L-1 chloride, showing the suitability of the HPLC-ICP-MS method for kinetic model studies. The first order rate constants k(1) of cisplatin aquation for the three chloride concentrations were 1.79x10(-5), 1.68x10(-5) and 2.06x10(-5) s(-1). For cisplatin anatation (second order reverse reaction), rate constants of k(-1)=6.5x10(-3), 5.8x10(-3) and 4.1x10(-3) M-1 s(-1) could be assessed. At low chloride levels, no equilibrium was established between cisplatin and its degradation products. It was found that the intermediately formed mono- and diaquacisplatin-products started to decay after several hours. Diluted urine of a cancer patient contained the parent drug cisplatin and a considerable fraction of highly active monoaquacisplatin, as well as several unknown platinum species.